Evaluation of serum and salivary interferon-gamma levels in patients with oral lichen planus: a systematic review and meta-analysis of case-control studies.

OBJECTIVE: Cytokines have regulatory and leading roles in the immunopathogenesis of oral lichen planus (OLP). Here, we present the findings of a meta-analysis that evaluated serum and salivary interferon-gamma (IFN-gamma) levels in patients with OLP compared with those in controls and the correlation of this cytokine with the progression of OLP. STUDY DESIGN: Four databases-PubMed, Web of Science, Scopus, and Cochrane Library-were searched, from their start dates to November 2017, for reports in all languages on the effect of OLP on salivary and serum IFN-gamma. RESULTS: Eleven studies were included and analyzed in this meta-analysis. The pooled mean difference (MD) values were estimated to be 3.60 pg/mL (P = .23) and -0.02 pg/mL (P = 1.00) for serum and salivary levels of IFN-gamma, respectively, in the patients with OLP compared with controls. The pooled MD values were -2.52 pg/mL (P = .03) and -2.01 pg/mL (P = .20) for serum and salivary IFN-gamma levels in the erosive type, respectively, compared with the nonerosive type. CONCLUSIONS: According to the results of meta-analysis, there was no statistically significant differences in IFN-gamma levels between the OLP group and the control group both in serum and salivary levels and also between erosive and nonerosive types of OLP at the salivary level; so this cytokine is not considered to have an important role in the pathogenesis or severity of OLP.